Filters
Other countries
Results: 1 to 8 of 8
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
UBA1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Hereditary Motor Neuropathy Panel Invitae United States | 60 | 26 |
|
Invitae Comprehensive Neuropathies Panel Invitae United States | 201 | 96 |
|
Inborn Errors of Immunity Panel with interpretation Clinical Genomics Laboratory Washington University in St. Louis United States | 8 | 9 |
|
Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing ARUP Laboratories, Molecular Oncology ARUP Laboratories United States | 6 | 65 |
|
VEXAS syndrome (search for somatic variants in codon 41 of the UBA1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Myeloid Malignancies Mutation Panel by Next Generation Sequencing ARUP Laboratories, Molecular Oncology ARUP Laboratories United States | 6 | 65 |
|
Somatic Overgrowth Panel with interpretation Clinical Genomics Laboratory Washington University in St. Louis United States | 86 | 49 |
|
Results: 1 to 8 of 8
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.